Testing effectiveness (Phase 2)Study completedNCT00734396What this trial is testingMesenchymal Stem Cells and Subclinical RejectionWho this might be right forOrgan Transplantation Leiden University Medical Center 15
Not applicableNot Yet RecruitingNCT05482100What this trial is testingCLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant RecipientsWho this might be right forKidney Transplant Rejection Transplant Genomics, Inc. 500
Not applicableNot Yet RecruitingNCT07231328What this trial is testingPIONEER Trial (Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients)Who this might be right forImmunosuppression ManagementBiomarkers / BloodSubclinical Rejection+2 more Transplant Genomics, Inc. 600
Not applicableUnknownNCT06013358What this trial is testingDdcfDNA in Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection Seoul National University Hospital 200
Not applicableUnknownNCT04491552What this trial is testingTruGraf® Long-term Clinical Outcomes StudyWho this might be right forKidney Transplant Rejection Transplant Genomics, Inc. 2,000
Not applicableUnknownNCT05335538What this trial is testingTruGraf and TRAC In Pediatrics StudyWho this might be right forKidney Transplant Rejection Transplant Genomics, Inc. 75
Not applicableUnknownNCT02664493What this trial is testingThe Effect of Steroid Pulse Therapy for the Reduction of Acute Rejection Episode in Subclinical Borderline ChangesWho this might be right forChronic Renal Failure Samsung Medical Center 154
Not applicableUnknownNCT02733510What this trial is testingThe Impact of Early Protocol Biopsy in Kidney TransplantWho this might be right forChronic Renal Failure Samsung Medical Center 200
Large-scale testing (Phase 3)Looking for participantsNCT03321656What this trial is testingImpact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic ProfileWho this might be right forEnd Stage Renal Disease Roberto Gedaly 78
Not applicableNot Yet RecruitingNCT05282966What this trial is testingAssessment of QSant™ for Underlying Allograft RejectionWho this might be right forKidney Transplant Failure and Rejection NephroSant 4,000
Very early researchEnded earlyNCT03380936What this trial is testingPilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection University of Colorado, Denver 4
Not applicableEnrolling By InvitationNCT06061341What this trial is testingTruGraf Liver Gene Expression Serial TestWho this might be right forAutoimmune Liver DiseaseAutoimmune HepatitisPrimary Sclerosing Cholangitis+1 more Washington University School of Medicine 20
Not applicableLooking for participantsNCT06112951What this trial is testingA Prospective Randomized Trial of ECP in Subclinical AMRWho this might be right forAntibody-mediated RejectionLung Transplant Rejection Medical University of Vienna 80
Not applicableLooking for participantsNCT04702022What this trial is testingAdded Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant PatientsWho this might be right forKidney Transplant RejectionKidney Transplant; Complications University of Liege 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06291103What this trial is testingScreening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)Who this might be right forKidney Transplant Rejection University Hospital, Rouen 290
Not applicableStudy completedNCT05747274What this trial is testingSRDK0921_ Analytical Performance StudyWho this might be right forKidney Transplant Rejection BioMAdvanced Diagnostics 439
Large-scale testing (Phase 3)Study completedNCT02005562What this trial is testingOPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.Who this might be right forKidney Transplantation Hoffmann-La Roche 252
Testing effectiveness (Phase 2)WithdrawnNCT02113891What this trial is testingEculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney TransplantationWho this might be right forSubclinical Acute Antibody-mediated Rejection in Kidney Transplantation Assistance Publique - Hôpitaux de Paris
Post-approval studies (Phase 4)Ended earlyNCT00133172What this trial is testingEffect of Rapid Steroid Withdrawal on Subclinical Markers of RejectionWho this might be right forKidney Transplantation Astellas Pharma Inc 85
Not applicableActive Not RecruitingNCT06564649What this trial is testingPROACT Pilot TrialWho this might be right forKidney Transplant Rejection University of British Columbia 60